Longmont, CO, United States of America

Erik James Hicken

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Erik James Hicken

Introduction

Erik James Hicken is a notable inventor based in Longmont, Colorado. He has made significant contributions to the field of pharmaceuticals, particularly in the development of HER2 mutation inhibitors. His work focuses on compounds that have the potential to treat abnormal cell growth, including cancer.

Latest Patents

Erik holds a patent for HER2 mutation inhibitors, which relates to compounds of Formula (I) and their enantiomers. This invention also includes pharmaceutically acceptable salts of these compounds. The patent outlines the pharmaceutical compositions that comprise such compounds and salts, as well as methods for their use in treating patients with abnormal cell growth.

Career Highlights

Erik is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role involves research and development of innovative treatments that can improve patient outcomes. With a focus on cancer therapies, Erik's work is crucial in advancing medical science.

Collaborations

Erik collaborates with talented professionals in his field, including Bryan Daniel Ellis and Ellen Ruth Laird. These partnerships enhance the research and development process, leading to more effective solutions in the pharmaceutical industry.

Conclusion

Erik James Hicken's contributions to the field of pharmaceuticals, particularly through his patent on HER2 mutation inhibitors, highlight his commitment to advancing cancer treatment. His work at Pfizer Corporation and collaborations with other professionals underscore the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…